11-MAR-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
  1 1 52 1 12 1 6
BREAST 1083 25 1304 99 1205 204 1242
ERLYTX 80 1 52 7 85 9 55
GI 186 3 157 14 170 26 158
GU 396 11 574 31 377 52 317
LEUK 133 0 0 8 97 16 97
LUNG 187 3 157 19 231 36 219
LYMPH 390 6 313 35 426 63 384
MELAN 219 0 0 0 0 0 0
MMYEL 117 3 157 11 134 16 97
MULT 26 2 104 3 37 3 18
OTHER 45 1 52 5 61 10 61
PREV 2 0 0 0 0 0 0
SXQOL 2 0 0 0 0 0 0
Total 2867 56 2922 233 2835 436 2654

11-MAR-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
  1 1 52 1 12 1 6
CCD 133 3 157 20 244 37 225
ERLYTX 10 0 0 0 0 0 0
GU 2 0 0 1 12 2 12
LEUK 613 14 730 49 597 102 621
LUNG 346 6 313 37 450 67 408
OTHER 34 0 0 0 0 1 6
PEOLC 123 2 104 7 85 8 49
PREV 220 2 104 12 146 34 207
SXQOL 577 9 470 64 779 106 645
Total 2059 37 1930 191 2325 358 2179

11-MAR-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
  2 2 104 2 24 2 12
BREAST 1083 25 1304 99 1205 204 1242
CCD 133 3 157 20 244 37 225
ERLYTX 90 1 52 7 85 9 55
GI 186 3 157 14 170 26 158
GU 398 11 574 32 390 54 329
LEUK 746 14 730 57 694 118 718
LUNG 533 9 470 56 682 103 627
LYMPH 390 6 313 35 426 63 384
MELAN 219 0 0 0 0 0 0
MMYEL 117 3 157 11 134 16 97
MULT 26 2 104 3 37 3 18
OTHER 79 1 52 5 61 11 67
PEOLC 123 2 104 7 85 8 49
PREV 222 2 104 12 146 34 207
SXQOL 579 9 470 64 779 106 645
Total 4926 93 4852 424 5162 794 4833

11-MAR-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
  1 1 52 1 12 1 6
BREAST 696 12 626 62 755 141 858
ERLYTX 46 1 52 4 49 5 30
GI 136 2 104 11 134 20 122
GU 322 8 417 22 268 37 225
LEUK 82 0 0 5 61 13 79
LUNG 120 2 104 14 170 26 158
LYMPH 256 4 209 26 317 42 256
MELAN 137 0 0 0 0 0 0
MMYEL 73 2 104 8 97 9 55
MULT 10 2 104 2 24 2 12
OTHER 45 1 52 5 61 10 61
PREV 2 0 0 0 0 0 0
SXQOL 2 0 0 0 0 0 0
Total 1928 35 1824 160 1948 306 1862

11-MAR-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
  1 1 52 1 12 1 6
CCD 117 3 157 19 231 34 207
ERLYTX 10 0 0 0 0 0 0
GU 2 0 0 1 12 2 12
LEUK 263 6 313 20 244 39 237
LUNG 218 5 261 22 268 36 219
OTHER 34 0 0 0 0 1 6
PEOLC 88 2 104 5 61 6 37
PREV 220 2 104 12 146 34 207
SXQOL 400 8 417 48 584 80 487
Total 1353 27 1408 128 1558 233 1418

11-MAR-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
  2 2 104 2 24 2 12
BREAST 886 14 730 79 962 179 1090
CCD 147 2 104 17 207 34 207
ERLYTX 56 1 52 4 49 5 30
GI 140 4 209 13 158 22 134
GU 347 10 522 24 292 45 274
LEUK 346 7 365 26 317 53 323
LUNG 347 8 417 38 463 67 408
LYMPH 256 4 209 26 317 42 256
MELAN 137 0 0 0 0 0 0
MMYEL 69 2 104 8 97 9 55
MULT 34 2 104 6 73 9 55
OTHER 236 2 104 13 158 26 158
PEOLC 88 2 104 5 61 7 43
PREV 222 2 104 12 146 34 207
SXQOL 402 8 417 48 584 80 487
Total 3715 70 3649 321 3908 614 3739

11-MAR-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES COORDINATED BY SWOG

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 897 23 1200 87 1059 161 980
ERLYTX 76 1 52 7 85 9 55
GI 107 1 52 8 97 16 97
GU 246 7 365 21 256 36 219
LEUK 100 0 0 7 85 10 61
LUNG 150 3 157 16 195 31 189
LYMPH 317 5 261 28 341 50 304
MMYEL 103 3 157 10 122 15 91
MULT 26 2 104 3 37 3 18
Total 2022 45 2348 187 2277 331 2014

11-MAR-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

Inst. Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
Member 1933 37 1931 164 1997 307 1869
AFFIL 138 0 0 4 49 21 128
CCOP/NCORP 1210 25 1304 120 1461 211 1284
Non-SWOG 1644 30 1565 135 1644 254 1546
Total 4925 92 4800 423 5151 793 4827

11-MAR-2026 6:11

STUDIES CLOSED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
SXQOL EAQ202 Improving AYA PROs in EA Trials 1 E 27-FEB-26
GU NRGGU010 Pros, Parallel De-Intens & Intens Trials 1 E 25-FEB-26
GU NRGGU010 Pros, Parallel De-Intens & Intens Trials 2 E 25-FEB-26
LEUK S1905 T-ALL/T-LBL, Rel/Ref, OBI-3424 1 N 15-FEB-26
LUNG S1933 NSCLC, Stg II-III, RT + Atezo 1 N 15-FEB-26
OTHER NRGBN011 Brain, Lomustine + Temo vs Temo 1 E 12-FEB-26
OTHER NRGBN011 Brain, Lomustine + Temo vs Temo 2 E 12-FEB-26
LYMPH S2207 LBCL, Transplant Inelig, Targeted Tx + Tafa 1 T 06-MAR-26
GU A031701 Bladder, ddGC for MIBC with DDR Tumor Alt 1 E 02-MAR-26
GU A031701 Bladder, ddGC for MIBC with DDR Tumor Alt 2 E 02-MAR-26
GU A031701 Bladder, ddGC for MIBC with DDR Tumor Alt 3 E 02-MAR-26

11-MAR-2026 6:11

STUDIES WITH 3 OR MORE REGISTRATIONS THIS WEEK

ADMIN STUDYID STNAME REGTYPE Registrations
BREAST S2212 Breast, TNBC, Neoadj Chemo + Pembro 1 18
LEUK MYELOMATCH MSRP for the NCI myeloMATCH Clinical Trials 1 14
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 1 12
LUNG LUNGMAP NSCLC, Adv, Master 1 6
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 2 5
LUNG LUNGMAP NSCLC, Adv, Master 2 4
SXQOL S2205 ICE COMPRESS: Reduction of CIPN from Taxanes 1 4
SXQOL NRGCC015 E-Mindfulness After Breast Cancer 0 3
SXQOL S2013 I-CHECKIT: ICI toxicity risk prediction study 1 3
MULT S2101 Melan or HNSCC, Adv, Cabo + Nivo 1 3
LYMPH S2308 FL, LTB, Mosunetuzumab vs Rituximab 1 3